ArticleHuman brain mapping2026
Characterising the Diffusion Functional Signature of Negative BOLD With Interleaved TMS-fMRI in the Human Brain.
Article in Human brain mapping, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The coupling between brain excitatory activity and positive blood oxygen level-dependent (BOLD) responses is well-established. Although often associated with inhibition, negative BOLD remains partially understood. Moving away from neurovascular coupling, apparent diffusion coefficient (ADC)-fMRI provides a more direct measure of excitatory activity, possibly mediated by transient cellular deformations. Diffusion-weighted fMRI (dfMRI), from which ADC-fMRI derives, combines vascular and microstructural contributions. While decreases in ADC align with positive BOLD, the possible translation of negative BOLD into positive ADC and the ability of ADC-fMRI to capture inhibitory activity remain unexplored in humans. In this study, we used transcranial magnetic stimulation (TMS)-fMRI on the right primary motor cortex (M1) to selectively induce contralateral negative BOLD responses, whilst acquiring interleaved fMRI. TMS was applied at 5 Hz, 90% resting motor threshold, for both BOLD-fMRI and ADC-fMRI contrasts, in n = 12 and n = 11 healthy participants, respectively. We replicated previously reported negative BOLD clusters in the contralateral M1 and primary somatosensory cortex (S1). This was accompanied by a negative dfMRI response, but no ADC-fMRI response, indicating minimal microstructural fluctuations. In ipsilateral M1/S1, no BOLD response was detected while dfMRI revealed a positive cluster, suggesting different sensitivity to the excitatory/inhibitory balance. Overall, combining the findings from BOLD-fMRI and ADC-fMRI provides new insights into the vascular and neuronal responses underlying subthreshold TMS and negative BOLD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.